Loading...
Loading...
Among the 8 tracked institutional investors we monitor, NTLA (Intellia Therapeutics Inc) is held with a combined value of $593.10M across 50,150,163 shares. The largest holder is ARK Investment Management LLC with a position worth $186.01M (1.45% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 5 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$593.10M
Total Shares Held
50,150,163
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | ARK Investment Management LLC | $186.01M | 1.45% | +2.1% |
| 2 | BlackRock, Inc. | $155.84M | 0.00% | +18.3% |
| 3 | VANGUARD GROUP INC | $116.96M | 0.00% | New |
| 4 | STATE STREET CORP | $88.75M | 0.00% | +7.8% |
| 5 | FMR LLC | $26.50M | 0.00% | +17.5% |
| 6 | CITADEL ADVISORS LLC | $14.33M | 0.00% | -47.7% |
| 7 | Point72 Asset Management, L.P. | $3.81M | 0.00% | +1132.4% |
| 8 | MILLENNIUM MANAGEMENT LLC | $904.57K | 0.00% | -44.2% |
As of the latest SEC 13F filings, ARK Investment Management LLC is the largest institutional holder of NTLA with a position worth $186.01M, representing 1.45% of their portfolio. In total, 8 institutional investors hold NTLA with a combined value of $593.10M.
In the most recent quarter, 1 fund opened a new position in NTLA. Additionally, 5 increased their holdings and 2 reduced their positions.
Institutional investors hold $593.10M worth of NTLA stock across 8 positions. The largest institutional holder is ARK Investment Management LLC with $186.01M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For NTLA, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their NTLA positions.